Ligand · TQI
TQI · N-{[4-chloro-3-(trifluoromethyl)phenyl]sulfonyl}-L-tryptophan
TQI, N-{[4-chloro-3-(trifluoromethyl)phenyl]sulfonyl}-L-tryptophan (C18 H14 Cl F3 N2 O4 S, 446.8 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the…
- Component
- TQI
- Formula
- C18 H14 Cl F3 N2 O4 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
TQI in 2 structures; the first of them:
- 2Y6C · The Discovery of MMP7 inhibitors Exploiting a Novel Selectivity Trigger · TQI A1269 · binds PHE103, THR180, LEU181, ALA182, HIS183, ALA184, TRP203, ILE211 and 9 more
- 2Y6C · The discovery of MMP7 inhibitors exploiting a novel selectivity trigger · TQI A1269 · binds PHE103, THR180, LEU181, ALA182, HIS183, ALA184, TRP203, ILE211 and 9 more
Residues it binds most
HIS 2, ALA 2, THR 2, TYR 2, GLU 2, ILE 2, LEU 2, PHE 2, PRO 2, TRP 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.